Serono Ltd. Sustainability Profile
Serono Ltd., a prominent player in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 1906, the company has a rich history marked by significant milestones, including its pioneering work in reproductive health and neurology. Specialising in innovative therapies, Serono is renowned for its unique offerings in areas such as multiple sclerosis and fertility treatments. Their commitment to research and development has positioned them as leaders in the biopharmaceutical industry, with a strong focus on patient-centric solutions. With a robust portfolio of core products, Serono Ltd. continues to achieve notable success, solidifying its market position as a trusted provider of advanced medical therapies. The company’s dedication to improving patient outcomes underscores its reputation as a forward-thinking organisation in the ever-evolving healthcare landscape.
DitchCarbon Score
How does Serono Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Serono Ltd.'s score of 59 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Serono Ltd., headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Merck KGaA, which influences its climate commitments and reporting practices. As part of its corporate family relationship, Serono Ltd. inherits climate initiatives and targets from Merck KGaA, which operates at a cascade level of 2. However, specific reduction targets or achievements for Serono Ltd. have not been detailed in the available data. Merck KGaA has established various climate initiatives, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to enhance transparency and drive significant reductions in greenhouse gas emissions across their operations. While Serono Ltd. does not currently provide specific emissions data or reduction targets, it aligns with the broader sustainability goals set by its parent company, Merck KGaA, to address climate change and reduce carbon footprints in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 352,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 402,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Serono Ltd.'s Industry?
How Carbon Intensive is Serono Ltd.'s Location?
Serono Ltd.'s Scope 3 Categories Breakdown
Serono Ltd.'s Scope 3 emissions, which decreased by 12% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Serono Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Serono Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
